Table 2 Patient’s Characteristics according to pathological Stage and Gleason score

Patients (%)

223 (64 %)

126 (36 %)

204 (58.5 %)

145 (41.5 %)

Age, years

63.44 ± 6.28 (65;59/68)

65.97 ± 5.97 (66;62/70)

<0.001

63.43 ± 6.16 (64;59/68)

64.69 ± 6.28 (66;61/69)

0.158

TRUS Volume, ml

76 ± 44.05 (60;44/96)

51.53 ± 29.86 (47;33.6/60)

<0.001

56.31 ± 31.57 (50;38/62.5)

53.23 ± 29.54 (49.5;35.5/57.9)

0.018

Waist, cm

99.30 ± 8.13 (98.87;96/102.77)

100.34 ± 9.22 (98.87;96/102.77)

0.503

99.21 ± 8.88 (99;94/105)

98.63 ± 10.89 (97;92/103)

0.549

BMI, kg/m²

26.64 ± 3.59 (26.98;24/28.65)

27.07 ± 3.79 (26.4;24/30)

0.149

26.51 ± 3.54 (26.98;24/28.4)

27.10 ± 3.8 (26.52;24/29.2)

0.131

PSA, ng/ml

7.81 ± 4.55 (6.8;4.79/9.43)

14.54 ± 17.84 (8.28;6.23/14.09)

<0.001

8.79 ± 8.16 (6.6;4.96/9.42)

13.22 ± 18.22 (8.7;6.15/11.7)

<0.001

Trygliceridemia, mg/dl

130.65 ± 63.4 (105;83/163)

136.23 ± 65.86 (122;86/161.5)

0.648

130.92 ± 50.74 (126;94/152)

135.25 ± 60 (126;94/152)

0.552

Glycaemia, mg/dl

100.83 ± 19.68 (98;91/104)

103.87 ± 21.1 (98;92/111)

0.159

100.19 ± 20.85 (95;88/107)

103.84 ± 23.15 (96;88/108)

0.153

HDL, mg/dl

52.14 ± 11.73 (52;45/56)

50.78 ± 12.34 (52;44/55.25)

0.925

52.1 ± 11.14 (52;46/55)

51.03 ± 12.99 (52;43/56.75)

0.213

Hypertension

102/223 (47 %)

74/126 (59 %)

0.037

88/204 (43 %)

91/145 (63 %)

0.001